Product Information
VIOKACE 10,440-39,150 UNIT TAB is a brand product labeled by Aimmune Therapeutics, Inc., priced at $4.1325 per EA under NDC 73562010410. Its NADAC has been published 88 times since Oct 23, 2024.
Strength
39150; 10440; 39150 [USP'U]/1; [USP'U]/1; [USP'U]/1
Manufacturer
Aimmune Therapeutics, Inc.NDC
73562010410
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PANCRELIPASE AMYLASE; PANCRELIPASE LIPASE; PANCRELIPASE PROTEASEApproval Type
Biologic (BLA)
FDA Application
BLA022542On Market Since
3/1/2021
Price Statistics
The NADAC for VIOKACE 10,440-39,150 UNIT TAB has been published 88 times since Oct 23, 2024, and over the history we have for it it has risen 2.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.1325 per EA |
|---|---|
| All-time high | $4.1629 (May 13, 2026) |
| All-time low | $4.0300 (Oct 23, 2024) |
| 52-week high | $4.1629 |
| 52-week low | $4.0411 |
| Median price | $4.0416 |
| Average price | $4.0718 |
| Largest weekly change | +3.0% (Jan 7, 2026) |
| Weeks tracked | 88 |
| Tracking since | Oct 23, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Pancrelipase market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of VIOKACE 10,440-39,150 UNIT TAB?
The current National Average Drug Acquisition Cost (NADAC) for VIOKACE 10,440-39,150 UNIT TAB, manufactured by Aimmune Therapeutics, Inc., is $4.1325 per EA (NDC 73562010410), effective Jun 24, 2026.
How has the price of VIOKACE 10,440-39,150 UNIT TAB changed over time?
Over the history we have for it, the NADAC for VIOKACE 10,440-39,150 UNIT TAB has risen 2.5%. It has been tracked across 88 weekly CMS publications since Oct 23, 2024.
What are the highest and lowest recorded NADAC prices for VIOKACE 10,440-39,150 UNIT TAB?
Since Oct 23, 2024, the NADAC for VIOKACE 10,440-39,150 UNIT TAB has ranged from a low of $4.0300 (Oct 23, 2024) to a high of $4.1629 (May 13, 2026), with a median of $4.0416 per EA.
Are there cheaper alternatives to VIOKACE 10,440-39,150 UNIT TAB?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of VIOKACE 10,440-39,150 UNIT TAB, so no direct lower-cost alternative is listed.
Who manufactures VIOKACE 10,440-39,150 UNIT TAB?
VIOKACE 10,440-39,150 UNIT TAB (NDC 73562010410) is labeled by Aimmune Therapeutics, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification